Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

TORCN

6 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in ADICET BIO INC

As of its Q3 2025 13F, JPMorgan Chase held 771 shares of TORCN (Adicet Bio), worth $625. JPMorgan Chase's 13F filings listed TORCN from Q3 2024 to Q3 2025, 5 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$115,708

Total Shares Change

-80,353

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Unchanged
771
0.0%
$6250.0%—
0
2025-Q2
Decreased
771
-34.1%
$4700.0%—
0
2025-Q1
Decreased
1,170
-99.2%
$8830.0%—
0
2024-Q4
Increased
150,485
+87.3%
$144,7660.0%—
24
2024-Q3
First report
80,353
-
$115,7080.0%—
0

Other major holders of TORCN: RTW Investments, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used